Table 1.
Patients' Characteristics
| Characteristic | NSM (n = 30) | ENSMSLS (n = 30) | P |
|---|---|---|---|
| Age, years | 43.87 ± 8.27 | 44.57 ± 8.84 | .75 |
| Follow-up, months | 43.22 ± 19.80 | 27.77 ± 20.43 | <.05* |
| Lymph node metastasis, n | 20/30 | 24/30 | .24 |
| Axillary dissection (ALND) | 11 (36.67) | 11 (36.67) | .99 |
| Multiple foci | 11 (36.67) | 13 (43.33) | .60 |
| Chemotherapy | 26 (86.67) | 24 (80.00) | .49 |
| Radiotherapy | 14 (46.67) | 13 (43.33) | .80 |
| Endocrine therapy | 23 (76.67) | 24 (80.00) | .75 |
| Reconstruction method | .96 | ||
| Implant | 18 (60.00) | 19 (63.33) | |
| Skin flap | 10 (33.33) | 9 (30.00) | |
| None | 2 (6.67) | 2 (6.67) | |
| Breast volume | .15 | ||
| A (<150 cc) | 6 (20.00) | 13 (43.33) | |
| B (150–250 cc) | 20 (66.67) | 14 (46.67) | |
| C and above (>250 cc) | 4 (13.33) | 3 (10.00) | |
| Breast-ptosis | 10 (33.33) | 5 (16.67) | .14 |
| SLN | 20 (66.67) | 25 (83.33) | .14 |
| Stage | .87 | ||
| None | 5 (16.67) | 5 (16.67) | |
| I | 4 (13.33) | 4 (13.33) | |
| IIA | 13 (43.33) | 14 (46.67) | |
| IIB | 1 (3.33) | 3 (10.00) | |
| IIIA | 7 (23.33) | 4 (13.33) | |
| Physician satisfied | 22 (73.33) | 23 (76.67) | .77 |
| Patient satisfied | 29 (96.67) | 29 (96.67) | .99 |
Stage: 2 patients of 11 with stage III cancer, who were T2N2M0. both had lymphatic metastasis. Unless otherwise indicated, the data are expressed as the number (% of the total group). ALND, axillary lymph node dissection.
*
Significantly different.